Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Reliance Chemotex Industries Limited (503162) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Reliance Chemotex Industries Limited ₹117, price ₹113, upside +3.0%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? No
- Add to watchlist
RC
Thin data
Sep 24, 2026
Reliance Chemotex Industries Limited
503162 · BSELow PriorityFair Value upside is limited and quality is weak.
·Fair value ₹116.80 · Fairly valued (+3.0%)
!Quality 49/100
!Mixed Growth (revenue 5y +3.6 %/yr)
!Thin margins · 1.7% net margin (TTM)
!Moderate debt
✓0.9% dividend yield · Well covered
!Narrow moat 24/100
!Evidence only low, so the estimate is less certain
Watch Reliance Chemotex Industries Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹69.77 – ₹326.31 · fair‑value band ₹88.48 – ₹116.80 · the ₹113.45 price screens below the ₹116.80 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Company profile
Reliance Chemotex Industries Limited manufactures and sells synthetic and blended yarns in India and internationally. It offers polyester, viscose, acrylic, and bamboo viscose yarns, as well as polyester/viscose, polyester/acrylic, and polyester/viscose/acrylic blended yarns for knitting, weaving, upholstery, carpet, medical, and other industrial end-uses.
Show more
Reliance Chemotex Industries Limited manufactures and sells synthetic and blended yarns in India and internationally. It offers polyester, viscose, acrylic, and bamboo viscose yarns, as well as polyester/viscose, polyester/acrylic, and polyester/viscose/acrylic blended yarns for knitting, weaving, upholstery, carpet, medical, and other industrial end-uses. The company was founded in 1977 and is based in Mumbai, India.
Stock analysis
Reliance Chemotex Industries Limited (503162) currently trades at ₹113.45, while our model-based Fair Value estimate is ₹116.80, so the stock looks roughly fairly valued today (gap 2.9%).
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ₹121.93 per share, and 7 of the 17 models we run sit above the ₹113.45 price.
Bear case: the Dividend Discount group reads lowest at ₹12.18, and 10 of the 17 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹88.48 (bear) to ₹116.80 (bull), the price of ₹113.45 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Industrial Goods sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Reliance Chemotex Industries Limited reported revenue of ₹3.6B in FY2025 versus ₹2.6B in FY2021, a compound +8.8%/yr. Reported net income was ₹40.5M in FY2025, compounding −12.6%/yr from FY2021.
Key figures
Market cap ₹856M (≈ $8.9M) · P/E ratio 22.8 · P/S ratio 0.26 · EPS (TTM) ₹6.07 · Dividend yield 0.9% · Net margin 1.1% · Return on assets (EBIT) 6.5% · Operating margin 5.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrial Goods peers we cover trades at −31% fair-value upside, at 3%, 503162 screens cheaper than that median.
Fair Value models
Bear ₹88.48
Fair Value ₹116.80
Bull ₹116.80
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then (₹5.07 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income
₹130.37
₹125.85
₹125.68
76
Owner Earnings
n/a
n/a
₹57.87
73
5Y Revenue Exit
n/a
₹38.22
>₹152.88
69
All 19 models by family
DCF Models
Owner Earnings
n/a
n/a
₹57.87
73
5Y Revenue Exit
n/a
₹38.22
>₹152.88
69
5Y EBITDA Exit
₹31.82
₹184.83
₹361.40
68
10Y Revenue Exit
n/a
n/a
₹59.71
63
10Y EBITDA Exit
n/a
₹66.77
₹202.08
65
Earnings-Based
Graham-Dodd
₹36.46
₹73.20
₹92.01
66
EPV
₹7.44
₹37.64
₹63.69
66
Dividend Discount
Gordon GGM
₹8.78
₹12.42
₹16.05
69
DDM Multi-Stage
₹8.78
₹12.18
₹15.96
67
Multiples
P/E Multiple
₹88.48
₹117.97
₹147.47
63
P/S Multiple
₹68.37
₹91.16
₹113.95
58
P/B Multiple
₹68.37
₹91.16
₹113.95
55
EV/EBIT
₹131.75
₹236.95
₹342.14
63
EV/EBITDA
₹201.55
₹330.01
₹458.47
66
EV/Revenue
₹28.90
₹120.07
₹211.23
48
Asset-Based
NCAV (Graham)
₹90.99
₹121.93
₹181.99
54
Economic Profit
Residual Income
₹130.37
₹125.85
₹125.68
76
ROIC Compounder
₹7.44
₹37.64
₹63.69
66
Growth Earnings
Growth-Adj P/E
₹64.04
₹91.48
₹118.93
67
Notify me when 503162 reaches fair value
Put 503162 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
49/100
Of which business quality 49 · Market factors (momentum, volatility) 25
Profitability
34
Margins and returns on capital today
Quality Growth
47
Are margins and returns improving?
Cashflow
41
Earnings quality: real cash, not paper profit
Fin. Strength
36
Balance sheet, leverage, solvency risk
Investment
71
Disciplined investing over empire-building
Low Volatility
51
Calm price path (market factor)
Momentum
20
Price trend over the last 3–12 months (market factor)
52W Momentum
3
Distance to the 52-week high (market factor)
Net Issuance
84
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
45/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−2.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
Start year 2020 (pandemic). Over 10 years: +4.3% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−5.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−6.0%
Dividend (yield on the price)0.9%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.8% → 5%
⚠ Revenue per share shrinking 5.1%/yr over ~6Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Watch 503162, get fair value alerts →
Compare Reliance Chemotex Industries Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Textile Industrial” was too small, so the broader sector is used.)Consumer Discretionary · 3585 stocks
Beats the sector median on 5/12 measures
A mixed picture versus its sector peers.
Valuation Multiplesvs Consumer Discretionary median · lower = cheaper
Context: sector, industry, market
- Is the Consumer Discretionary sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Textile Industrial stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Raymond Limited 500330 | ₹1,199 | ₹350.92 | −71% |
| BETXIND BETXIND | ₹510.00 | ₹398.53 | −22% |
| Deepak Spinners Limited 514030 | ₹137.60 | ₹86.59 | −37% |
| KG Petrochem Limited 531609 | ₹190.00 | ₹144.94 | −24% |
| Dhanlaxmi Fabrics Limited 521151 | ₹53.04 | ₹16.19 | −69% |
| Anjani Synthetics Limited 531223 | ₹29.22 | ₹46.47 | +59% |
| TUNITEX TUNITEX | ₹1.82 | ₹3.23 | +77% |
| Aditya Spinners Limited 521141 | ₹15.00 | ₹10.28 | −31% |
| FRONTSP FRONTSP | ₹1,417 | ₹889.77 | −37% |
| DISAQ DISAQ | ₹11,343 | ₹4,347 | −62% |
Explore undervalued stocks
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Reliance Chemotex Industries Limited (503162) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹116.80 versus a price of ₹113.45, about +3% upside (fairly valued).
What is the fair value of 503162?
Our model-based fair value for Reliance Chemotex Industries Limited is ₹116.80 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹113.45.
What is the quality score of 503162?
Reliance Chemotex Industries Limited has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Reliance Chemotex Industries Limited (503162)?
Our model-based price target is the fair value of ₹116.80 (as of Sep 24, 2026) from 19 valuation models. Cautious scenario ₹88.48, optimistic scenario ₹116.80. It is a calculation from audited fundamentals, not an analyst target.
What is the Reliance Chemotex Industries Limited stock forecast for 2026?
Our models put fair value at ₹116.80, about +3% upside versus a price of ₹113.45 (fairly valued). Cautious scenario ₹88.48, optimistic scenario ₹116.80. The calculation is refreshed regularly with new filings.
What is the revenue of Reliance Chemotex Industries Limited (503162)?
Reliance Chemotex Industries Limited reported trailing-twelve-month revenue of about ₹2.6B (latest available figure, as of Sep 24, 2026).
Does Reliance Chemotex Industries Limited pay a dividend?
Reliance Chemotex Industries Limited currently shows a dividend yield of about 0.88% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Reliance Chemotex Industries Limited (503162)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Reliance Chemotex Industries Limited it is ₹116.80 per share (as of Sep 24, 2026), against a price of ₹113.45. It is the blended result of 19 valuation models (cash flow, earnings, asset, dividend).
Is Reliance Chemotex Industries Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 503162 trades below its calculated fair value: price ₹113.45, fair value ₹116.80, a gap of about +3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 503162?
No. The price is what the market pays today (₹113.45); the fair value is what the company's own numbers justify (₹116.80). For Reliance Chemotex Industries Limited the two are ₹3.35 per share apart. That gap is exactly why we show both numbers side by side.
How much is Reliance Chemotex Industries Limited worth?
The market values Reliance Chemotex Industries Limited at about ₹856M (market capitalisation, as of Sep 24, 2026). Per share that is ₹113.45; our models calculate a fair value of ₹116.80 per share.
What do the bullish and bearish scenarios say about 503162?
Our models span a range for Reliance Chemotex Industries Limited: cautious scenario ₹88.48, base ₹116.80, optimistic ₹116.80 per share (as of Sep 24, 2026, price ₹113.45). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 503162?
Reliance Chemotex Industries Limited trades at a price-to-earnings ratio of 22.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹116.80 is built from several models across several years. Other multiples: P/B 0.3, P/S 0.2, EV/EBITDA 8.0.
How solid is the balance sheet of Reliance Chemotex Industries Limited (503162)?
Balance-sheet figures for Reliance Chemotex Industries Limited (as of Sep 24, 2026): debt of 1.01 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 503162 from its 52-week high?
Reliance Chemotex Industries Limited trades at ₹113.45, about 28% below its 52-week high of ₹158.40 and 4% above the low of ₹109.50 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹116.80 is for.
Which stocks are comparable to Reliance Chemotex Industries Limited?
From the same area (Industrial Goods) we also value Raymond Limited, BETXIND, Deepak Spinners Limited, KG Petrochem Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Reliance Chemotex Industries Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹113.45, calculated fair value ₹116.80 (+3%), Quality Score 49/100, from 19 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 503162 calculated?
We run Reliance Chemotex Industries Limited through 19 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹116.80, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Reliance Chemotex Industries Limited currently trades 3 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Reliance Chemotex Industries Limited (503162)?
The closing price on Oct 1, 2026 was ₹113.45. Our model-based fair value is ₹116.80, about +3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Reliance Chemotex Industries Limited right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Reliance Chemotex Industries Limited
How large is the market capitalisation of Reliance Chemotex Industries Limited (503162)?
The market capitalisation of Reliance Chemotex Industries Limited is ₹856M (≈ $8.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Reliance Chemotex Industries Limited (503162)?
The price-to-sales ratio of Reliance Chemotex Industries Limited is 0.26 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Reliance Chemotex Industries Limited (503162)?
Earnings per share at Reliance Chemotex Industries Limited are ₹6.07 (price ÷ EPS = P/E 22.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Reliance Chemotex Industries Limited (503162)?
The dividend yield of Reliance Chemotex Industries Limited is 0.9% (payout 16.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Reliance Chemotex Industries Limited (503162)?
The net margin of Reliance Chemotex Industries Limited is 1.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Reliance Chemotex Industries Limited (503162)?
On an EBIT basis the return on assets of Reliance Chemotex Industries Limited is 6.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Reliance Chemotex Industries Limited (503162)?
The operating margin of Reliance Chemotex Industries Limited is 5.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Reliance Chemotex Industries Limited (503162)?
Revenue at Reliance Chemotex Industries Limited is growing −47.6% versus a year earlier (3y avg −0.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
Free · no account needed
Watch Reliance Chemotex Industries Limited in the live analysis
One click puts Reliance Chemotex Industries Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.